WhichRecall
Class IIReported 2025-08-20

Carvedilol Tablets, USP, 25 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 47430 NDC: 68462-165-05

Recalled by Glenmark Pharmaceuticals Inc., USA

Reason for Recall

CGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm

Advertisement
Recall Number
D-0588-2025
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-08-06
Reported
2025-08-20
Distribution
Nationwide within the USA
Code Info
Lot #: 17241213, 17241215, 17241224, Exp. Date 06/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement